VEGFA c.31_32inv ;(p.S11L)

Variant ID: 6-43738474-AG-CT

NM_003376.5(VEGFA):c.31_32inv;(p.S11L)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function.

Iranian Journal Of Basic Medical Sciences
Kazemi-Lomedasht, Fatemeh F; Muyldermans, Serge S; Habibi-Anbouhi, Mahdi M; Behdani, Mahdi M
Publication Date: 2018-03

Variant appearance in text: VEGF: S11L
PubMed Link: 29511492
Variant Present in the following documents:
  • Main text
  • IJBMS-21-260.pdf
View BVdb publication page



Involvement of Ubiquitin-Editing Protein A20 in Modulating Inflammation in Rat Cochlea Associated with Silver Nanoparticle-Induced CD68 Upregulation and TLR4 Activation.

Nanoscale Research Letters
Feng, Hao H; Pyykkö, Ilmari I; Zou, Jing J
Publication Date: 2016-12

Variant appearance in text: VEGF: S11L
PubMed Link: 27142878
Variant Present in the following documents:
  • Main text
  • 11671_2016_Article_1430.pdf
View BVdb publication page



Lysophosphatidic acid acts as a nutrient-derived developmental cue to regulate early hematopoiesis.

The Embo Journal
Li, Haisen H; Yue, Rui R; Wei, Bin B; Gao, Ge G; Du, Jiulin J; Pei, Gang G
Publication Date: 2014-06-17

Variant appearance in text: VEGF: S11L
PubMed Link: 24829209
Variant Present in the following documents:
  • Main text
View BVdb publication page